pharmaceutical

Tech

Hong Kong scientist behind artificial ‘mini-hearts’ takes Novoheart closer to China with facilities to quicken drug discovery process

Novoheart Holdings, the inventor of artificial “mini-hearts” co-founded by a Hong Kong scientist, is expanding its research and manufacturing budget…

Read More »
Tech

Coronavirus in China: 2021 outlook brightens for health care operators, pharmaceutical and device makers after price cuts

An MSCI index tracking 81 Chinese health care stocks with a combined market value of HK$1.15 trillion (US$148 billion) advanced…

Read More »
Back to top button